Cargando…

Proteomic Analysis of Kveim Reagent Identifies Targets of Cellular Immunity in Sarcoidosis

BACKGROUND: Kveim-reagent (Kv) skin testing was a historical method of diagnosing sarcoidosis. Intradermal injection of treated sarcoidosis spleen tissue resulted in a granuloma response at injection site by 4–6 weeks. Previous work indicates proteins as the possible trigger of this reaction. We aim...

Descripción completa

Detalles Bibliográficos
Autores principales: Eberhardt, Christian, Thillai, Muhunthan, Parker, Robert, Siddiqui, Nazneen, Potiphar, Lee, Goldin, Rob, Timms, John F., Wells, Athol U., Kon, Onn M., Wickremasinghe, Melissa, Mitchell, Donald, Weeks, Mark E., Lalvani, Ajit
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5256960/
https://www.ncbi.nlm.nih.gov/pubmed/28114394
http://dx.doi.org/10.1371/journal.pone.0170285
_version_ 1782498787806150656
author Eberhardt, Christian
Thillai, Muhunthan
Parker, Robert
Siddiqui, Nazneen
Potiphar, Lee
Goldin, Rob
Timms, John F.
Wells, Athol U.
Kon, Onn M.
Wickremasinghe, Melissa
Mitchell, Donald
Weeks, Mark E.
Lalvani, Ajit
author_facet Eberhardt, Christian
Thillai, Muhunthan
Parker, Robert
Siddiqui, Nazneen
Potiphar, Lee
Goldin, Rob
Timms, John F.
Wells, Athol U.
Kon, Onn M.
Wickremasinghe, Melissa
Mitchell, Donald
Weeks, Mark E.
Lalvani, Ajit
author_sort Eberhardt, Christian
collection PubMed
description BACKGROUND: Kveim-reagent (Kv) skin testing was a historical method of diagnosing sarcoidosis. Intradermal injection of treated sarcoidosis spleen tissue resulted in a granuloma response at injection site by 4–6 weeks. Previous work indicates proteins as the possible trigger of this reaction. We aimed to identify Kv-specific proteins and characterise the ex vivo response of Peripheral Blood Mononuclear Cells (PBMCs) from sarcoidosis, tuberculosis and healthy control patients when stimulated with both Kv and selected Kv-specific proteins. METHODS: Kv extracts were separated by 1D-SDS-PAGE and 2D-DIGE and then underwent mass spectrometric analysis for protein identification. Sarcoidosis and control PBMCs were first stimulated with Kv and then with three selected recombinant protein candidates which were identified from the proteomic analysis. PBMC secreted cytokines were subsequently measured by Multiplex Cytokine Assay. RESULTS: We observed significantly increased IFN-γ and TNF-α secretion from Kv-stimulated PBMCs of sarcoidosis patients vs. PBMCs from healthy volunteers (IFN-γ: 207.2 pg/mL vs. 3.86 pg/mL, p = 0.0018; TNF-α: 2375 pg/mL vs. 42.82 pg/mL, p = 0.0003). Through proteomic approaches we then identified 74 sarcoidosis tissue-specific proteins. Of these, 3 proteins (vimentin, tubulin and alpha-actinin-4) were identified using both 1D-SDS-PAGE and 2D-DIGE. Data are available via ProteomeXchange with identifier PXD005150. Increased cytokine secretion was subsequently observed with vimentin stimulation of sarcoidosis PBMCs vs. tuberculosis PBMCs (IFN-γ: 396.6 pg/mL vs 0.1 pg/mL, p = 0.0009; TNF-α: 1139 pg/mL vs 0.1 pg/mL, p<0.0001). This finding was also observed in vimentin stimulation of sarcoidosis PBMCs compared to PBMCs from healthy controls (IFN-γ: 396.6 pg/mL vs. 0.1 pg/mL, p = 0.014; TNF-α: 1139 pg/mL vs 42.29 pg/mL, p = 0.027). No difference was found in cytokine secretion between sarcoidosis and control PBMCs when stimulated with either tubulin or alpha-actinin-4. CONCLUSIONS: Stimulation with both Kveim reagent and vimentin induces a specific pro-inflammatory cytokine secretion from sarcoidosis PBMCs. Further investigation of cellular immune responses to Kveim-specific proteins may identify novel biomarkers to assist the diagnosis of sarcoidosis.
format Online
Article
Text
id pubmed-5256960
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-52569602017-02-06 Proteomic Analysis of Kveim Reagent Identifies Targets of Cellular Immunity in Sarcoidosis Eberhardt, Christian Thillai, Muhunthan Parker, Robert Siddiqui, Nazneen Potiphar, Lee Goldin, Rob Timms, John F. Wells, Athol U. Kon, Onn M. Wickremasinghe, Melissa Mitchell, Donald Weeks, Mark E. Lalvani, Ajit PLoS One Research Article BACKGROUND: Kveim-reagent (Kv) skin testing was a historical method of diagnosing sarcoidosis. Intradermal injection of treated sarcoidosis spleen tissue resulted in a granuloma response at injection site by 4–6 weeks. Previous work indicates proteins as the possible trigger of this reaction. We aimed to identify Kv-specific proteins and characterise the ex vivo response of Peripheral Blood Mononuclear Cells (PBMCs) from sarcoidosis, tuberculosis and healthy control patients when stimulated with both Kv and selected Kv-specific proteins. METHODS: Kv extracts were separated by 1D-SDS-PAGE and 2D-DIGE and then underwent mass spectrometric analysis for protein identification. Sarcoidosis and control PBMCs were first stimulated with Kv and then with three selected recombinant protein candidates which were identified from the proteomic analysis. PBMC secreted cytokines were subsequently measured by Multiplex Cytokine Assay. RESULTS: We observed significantly increased IFN-γ and TNF-α secretion from Kv-stimulated PBMCs of sarcoidosis patients vs. PBMCs from healthy volunteers (IFN-γ: 207.2 pg/mL vs. 3.86 pg/mL, p = 0.0018; TNF-α: 2375 pg/mL vs. 42.82 pg/mL, p = 0.0003). Through proteomic approaches we then identified 74 sarcoidosis tissue-specific proteins. Of these, 3 proteins (vimentin, tubulin and alpha-actinin-4) were identified using both 1D-SDS-PAGE and 2D-DIGE. Data are available via ProteomeXchange with identifier PXD005150. Increased cytokine secretion was subsequently observed with vimentin stimulation of sarcoidosis PBMCs vs. tuberculosis PBMCs (IFN-γ: 396.6 pg/mL vs 0.1 pg/mL, p = 0.0009; TNF-α: 1139 pg/mL vs 0.1 pg/mL, p<0.0001). This finding was also observed in vimentin stimulation of sarcoidosis PBMCs compared to PBMCs from healthy controls (IFN-γ: 396.6 pg/mL vs. 0.1 pg/mL, p = 0.014; TNF-α: 1139 pg/mL vs 42.29 pg/mL, p = 0.027). No difference was found in cytokine secretion between sarcoidosis and control PBMCs when stimulated with either tubulin or alpha-actinin-4. CONCLUSIONS: Stimulation with both Kveim reagent and vimentin induces a specific pro-inflammatory cytokine secretion from sarcoidosis PBMCs. Further investigation of cellular immune responses to Kveim-specific proteins may identify novel biomarkers to assist the diagnosis of sarcoidosis. Public Library of Science 2017-01-23 /pmc/articles/PMC5256960/ /pubmed/28114394 http://dx.doi.org/10.1371/journal.pone.0170285 Text en © 2017 Eberhardt et al http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Article
Eberhardt, Christian
Thillai, Muhunthan
Parker, Robert
Siddiqui, Nazneen
Potiphar, Lee
Goldin, Rob
Timms, John F.
Wells, Athol U.
Kon, Onn M.
Wickremasinghe, Melissa
Mitchell, Donald
Weeks, Mark E.
Lalvani, Ajit
Proteomic Analysis of Kveim Reagent Identifies Targets of Cellular Immunity in Sarcoidosis
title Proteomic Analysis of Kveim Reagent Identifies Targets of Cellular Immunity in Sarcoidosis
title_full Proteomic Analysis of Kveim Reagent Identifies Targets of Cellular Immunity in Sarcoidosis
title_fullStr Proteomic Analysis of Kveim Reagent Identifies Targets of Cellular Immunity in Sarcoidosis
title_full_unstemmed Proteomic Analysis of Kveim Reagent Identifies Targets of Cellular Immunity in Sarcoidosis
title_short Proteomic Analysis of Kveim Reagent Identifies Targets of Cellular Immunity in Sarcoidosis
title_sort proteomic analysis of kveim reagent identifies targets of cellular immunity in sarcoidosis
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5256960/
https://www.ncbi.nlm.nih.gov/pubmed/28114394
http://dx.doi.org/10.1371/journal.pone.0170285
work_keys_str_mv AT eberhardtchristian proteomicanalysisofkveimreagentidentifiestargetsofcellularimmunityinsarcoidosis
AT thillaimuhunthan proteomicanalysisofkveimreagentidentifiestargetsofcellularimmunityinsarcoidosis
AT parkerrobert proteomicanalysisofkveimreagentidentifiestargetsofcellularimmunityinsarcoidosis
AT siddiquinazneen proteomicanalysisofkveimreagentidentifiestargetsofcellularimmunityinsarcoidosis
AT potipharlee proteomicanalysisofkveimreagentidentifiestargetsofcellularimmunityinsarcoidosis
AT goldinrob proteomicanalysisofkveimreagentidentifiestargetsofcellularimmunityinsarcoidosis
AT timmsjohnf proteomicanalysisofkveimreagentidentifiestargetsofcellularimmunityinsarcoidosis
AT wellsatholu proteomicanalysisofkveimreagentidentifiestargetsofcellularimmunityinsarcoidosis
AT kononnm proteomicanalysisofkveimreagentidentifiestargetsofcellularimmunityinsarcoidosis
AT wickremasinghemelissa proteomicanalysisofkveimreagentidentifiestargetsofcellularimmunityinsarcoidosis
AT mitchelldonald proteomicanalysisofkveimreagentidentifiestargetsofcellularimmunityinsarcoidosis
AT weeksmarke proteomicanalysisofkveimreagentidentifiestargetsofcellularimmunityinsarcoidosis
AT lalvaniajit proteomicanalysisofkveimreagentidentifiestargetsofcellularimmunityinsarcoidosis